The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Open accessAbstract
Tuberous sclerosis complex (TSC) is a genetic disease caused by mutation in either TSC1 or TSC2 . The TSC1 and TSC2 gene products form a functional complex and inhibit phosphorylation of S6K and 4EBP1. These functions of TSC1/TSC2 are likely mediated by mTOR. Here we report that TSC2 is a GTPase-activating protein (GAP) toward Rheb, a Ras family GTPase. Rheb stimulates phosphorylation of S6K and 4EBP1. This function of Rheb is blocked by rapamycin and dominant-negative mTOR. Rheb stimulates the phosphorylation of mTOR and plays an essential role in regulation of S6K and 4EBP1 in response to nutrients and cellular energy status. Our data demonstrate that Rheb acts downstream of TSC1/TSC2 and upstream of mTOR to regulate cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“mTORC1-TFEB signaling governs lysosomal biogenesis (Laplante and Sabatini 2012), (Inoki et al. 2003), (Tee et al. 2003), (Sardiello et al. 2009), (Settembre et al. 2012), (Settembre et al. 2013), (Sardiello et al. 2009), (Martina et al. 2014), and TFEB targets include several genes, including MCOLN1 (Nnah et al. 2019).”
From TMEM55B downregulation promotes neurodegeneration in Alzheimer’s disease models (2026) · cites this paper as Inoki et al. 2003
Experimental — accuracy not yet measuredIn the citing paper
“The TSC complex (TSCC) acts as a GTPase activating protein (GAP) for Rheb, employing a GAP domain within the TSC2 subunit”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Inoki et al., 2003
In the citing paper
“Activation of mTORC1 by Rheb downstream of growth-factor signaling (Inoki et al. 2003), (Tee et al. 2003), controls lysosomal and autophagosome biogenesis via TFEB and the CLEAR gene network (Sardiello et al. 2009), (Settembre et al. 2012).”
From TMEM55B downregulation promotes neurodegeneration in Alzheimer’s disease models (2026) · cites this paper as Inoki et al. 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Self-citationeIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,103
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., BELHAM, C. M., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,370
A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic Mutants
Trahey, M., & McCormick, F. (1987) · Science · doi:10.1126/science.2821624 · Cited by 1,211
FUNCTION AND REGULATION OF RAS
Lowy, D. R., & Willumsen, B. M. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.004223 · Cited by 1,164
Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827
Flagged first, then by citations
Research works printed but not linked: 1
- 2002, Cancer Res., 62, 5645
Cited by
Sorted by citations
Items 301–400 of 1,009
Autophagy in kidney disease and aging: lessons from rodent models
Lenoir, O., Tharaux, P., & Huber, T. B. (2016) · Kidney International · doi:10.1016/j.kint.2016.04.014 · Cited by 156
The immunobiology of mTOR in autoimmunity
Suto, T., & Karonitsch, T. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102373 · Cited by 149
Regulation of mTORC1 by the Rab and Arf GTPases
Li, L., Kim, E., Yuan, H., Inoki, K., Goraksha-Hicks, P., Schiesher, R. L., Neufeld, T. P., & Guan, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.102483 · Cited by 153
Self-citationKlempner, S. J., Myers, A. P., & Cantley, L. C. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0063 · Cited by 148
G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling
Prentzell, M. T., Rehbein, U., Sandoval, M. C., Meulemeester, A. D., Baumeister, R., Brohée, L., Berdel, B., Bockwoldt, M., Carroll, B., Chowdhury, S. R., et al. (2021) · Cell · doi:10.1016/j.cell.2020.12.024 · Cited by 148
Wang, X., Ji, Y., Feng, P., Liu, R., Li, G., Zheng, J., Xue, Y., Wei, Y., Ji, C., Chen, D., et al. (2021) · Advanced Science · doi:10.1002/advs.202100209 · Cited by 147
Obesity, metabolic syndrome and esophageal adenocarcinoma: Epidemiology, etiology and new targets
Ryan, A. M., Duong, M. T., Healy, L., Ryan, S. A., Parekh, N., Reynolds, J. V., & Power, D. G. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.03.001 · Cited by 151
Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase
Emmanuel, N., Ragunathan, S., Shan, Q., Wang, F., Giannakou, A., Huser, N. H., Jin, G., Myers, J. S., Abraham, R. T., & Ünsal-Kaçmaz, K. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.043 · Cited by 145
Pradelli, L. A., Bénéteau, M., Chauvin, C., Jacquin, M. A., Marchetti, S., Muñoz‐Pinedo, C., Auberger, P., Pende, M., & Ricci, J. (2009) · Oncogene · doi:10.1038/onc.2009.448 · Cited by 144
IL-15–PI3K–AKT–mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells
Ali, A. K., Nandagopal, N., & Lee, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00355 · Cited by 152
Vitale-Cross, L. A., Molinolo, A., Martín, D., Younis, R. H., Maruyama, T., Patel, V., Chen, W., Schneider, A., & Gutkind, J. S. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0502 · Cited by 145
Nutrient sensing and metabolic decisions
Lindsley, J. E., & Rutter, J. P. (2004) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2004.06.014 · Cited by 146
The Opposing Actions of Target of Rapamycin and AMP-Activated Protein Kinase in Cell Growth ControlPreprint
Hindupur, S. K., González, A., & Hall, M. N. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019141 · Cited by 147
Carlson, E. S., Stead, J. D. H., Neal, C. R., Petryk, A., & Georgieff, M. K. (2007) · Hippocampus · doi:10.1002/hipo.20307 · Cited by 141
TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF- Mutant Melanoma
Corcoran, R. B., Rothenberg, S. M., Hata, A. N., Faber, A. C., Piris, A., Nazarian, R. M., Brown, R. D., Godfrey, J. T., Winokur, D., Walsh, J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005753 · Cited by 140
AMPK: A cellular metabolic and redox sensor. A minireview
Shirwany, N. A. (2014) · Frontiers in bioscience · doi:10.2741/4218 · Cited by 143
Tzatsos, A., & Tsichlis, P. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610101200 · Cited by 140
mTOR signaling for biological control and cancer
Alayev, A., & Holz, M. K. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24351 · Cited by 143
The Circadian Protein Period2 Suppresses mTORC1 Activity via Recruiting Tsc1 to mTORC1 Complex
Wu, R., Dang, F., Li, P., Wang, P., Xu, Q., Liu, Z., Li, Y., Wu, Y., Chen, Y., & Liu, Y. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.11.006 · Cited by 138
Self-citationNon-canonical mTORC1 signaling at the lysosome
Napolitano, G., Malta, C. D., & Ballabio, A. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.04.012 · Cited by 139
Regulation of mTOR by amino acids and resistance exercise in skeletal muscle
Deldicque, L., Theisen, D., & Francaux, M. (2005) · European Journal of Applied Physiology · doi:10.1007/s00421-004-1255-6 · Cited by 147
Morita, T., & Sobue, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008177 · Cited by 145
Zheng, M., Wang, Y., Wu, X., Wu, S., Lu, B.-J., Dong, M., Zhang, H., Sun, P., Lin, S., Guan, K., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2168 · Cited by 142
Self-citationRole of Polyamines in Immune Cell Functions
Hesterberg, R. S., Cleveland, J. L., & Epling‐Burnette, P. K. (2018) · Medical Sciences · doi:10.3390/medsci6010022 · Cited by 142
mTOR: A Cellular Regulator Interface in Health and Disease
Boutouja, F., Stiehm, C. M., & Platta, H. W. (2019) · Cells · doi:10.3390/cells8010018 · Cited by 139
Goodman, C. A. (2013) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2013_17 · Cited by 145
van Dam, T. J. P., Zwartkruis, F. J. T., Bos, J. L., & Snel, . (2011) · Journal of Molecular Evolution · doi:10.1007/s00239-011-9469-9 · Cited by 147
Role of TOR signaling in aging and related biological processes in Drosophila melanogaster
Katewa, S. D., & Kapahi, P. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.036 · Cited by 139
Sugiyama, M. G., Fairn, G. D., & Antonescu, C. N. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00070 · Cited by 140
Dysregulation of Nutrient Sensing and CLEARance in Presenilin Deficiency
Reddy, K., Cusack, C. L., Nnah, I. C., Khayati, K., Saqcena, C., Huynh, T., Noggle, S., Ballabio, A., & Dobrowolski, R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.006 · Cited by 136
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Ata, R., & Antonescu, C. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010189 · Cited by 139
Cryo-EM Structure of the Human FLCN-FNIP2-Rag-Ragulator Complex
Shen, K., Rogala, K. B., Chou, H., Huang, R. K., Yu, Z., & Sabatini, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.036 · Cited by 135
Regulation of the small GTPase Rheb by amino acids
Roccio, M., Bos, J. L., & Zwartkruis, F. J. T. (2005) · Oncogene · doi:10.1038/sj.onc.1209106 · Cited by 135
Patursky-Polischuk, I., Stolovich-Rain, M., Hausner-Hanochi, M., Kasir, J., Cybulski, N., Avruch, J., Rüegg, M. A., Hall, M. N., & Meyuhas, O. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00980-08 · Cited by 139
SREBP: a novel therapeutic target
Xu, X., & Song, B. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms112 · Cited by 137
Szymonowicz, K., Oeck, S., Malewicz, N. M., & Jendrossek, V. (2018) · Cancers · doi:10.3390/cancers10030078 · Cited by 135
The Systemic Control of GrowthPreprint
Boulan, L., Milán, M., & Léopold, P. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019117 · Cited by 120
Kimball, S. R., Siegfried, B. A., & Jefferson, L. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410755200 · Cited by 133
Hartman, T. R., Liu, D., Zilfou, J. T., Robb, V. A., Morrison, T. A., Watnick, T. J., & Henske, E. P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn325 · Cited by 136
Li, X.-Y., Wang, S.-S., Han, Z., Han, F., Chang, Y.-P., Yang, Y., Xue, M., Sun, B., & Chen, L.-M. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.08.011 · Cited by 132
Martin, T. D., Chen, X., Kaplan, R. E. W., Saltiel, A. R., Walker, C. L., Reiner, D. J., & Der, C. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.004 · Cited by 133
mTOR controls lysosome tubulation and antigen presentation in macrophages and dendritic cells
Sarić, A., Hipolito, V. E. B., Kay, J. G., Canton, J., Antonescu, C. N., & Botelho, R. J. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-05-0272 · Cited by 127
Condon, K. J., Orozco, J. M., Adelmann, C. H., Spinelli, J. B., van der Helm, P. W., Roberts, J. M., Kunchok, T., & Sabatini, D. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022120118 · Cited by 137
Growth Control Under Stress: mTOR Regulation through the REDD1-TSC Pathway
Ellisen, L. W. (2005) · Cell Cycle · doi:10.4161/cc.4.11.2139 · Cited by 131
An emerging role for TOR signaling in mammalian tissue and stem cell physiology
Russell, R. C., Fang, C., & Guan, K. (2011) · Development · doi:10.1242/dev.058230 · Cited by 136
Self-citationPI3-kinase and TOR: PIKTORing cell growth
Richardson, C. J., Schalm, S. S., & Blenis, J. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.023 · Cited by 130
ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling
Winter, J. N., Jefferson, L. S., & Kimball, S. R. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00504.2010 · Cited by 135
Fuchs, B. C., Finger, R., Onan, M. C., & Bode, B. P. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00330.2006 · Cited by 137
Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling
Li, M., Zhao, L., Liu, J., Liu, A., Jia, C., Ma, D., Jiang, Y., & Bai, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.015 · Cited by 132
Dengue Virus Activates the AMP Kinase-mTOR Axis To Stimulate a Proviral Lipophagy
Jordan, T. X., & Randall, G. C. (2017) · Journal of Virology · doi:10.1128/jvi.02020-16 · Cited by 135
A Ragulator–BORC interaction controls lysosome positioning in response to amino acid availability
Pu, J., Keren‐Kaplan, T., & Bonifacino, J. S. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201703094 · Cited by 124
Exercise-induced skeletal muscle signaling pathways and human athletic performance
Camera, D. M., Smiles, W. J., & Hawley, J. A. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.007 · Cited by 128
The Rap–RapGAP complex: GTP hydrolysis without catalytic glutamine and arginine residues
Scrima, A., Thomas, C., Deaconescu, D., & Wittinghofer, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.30 · Cited by 127
Balcázar, N., Sathyamurthy, A., Elghazi, L., Gould, A. P., Weiss, A., Shiojima, I., Walsh, K. X., & Bernal‐Mizrachi, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807458200 · Cited by 126
Rheb1 Is Required for mTORC1 and Myelination in Postnatal Brain Development
Zou, J., Zhou, L., Du, X.-X., Ji, Y.-F., Xu, J., Tian, J., Jiang, W., Zou, Y., Yu, S., Gan, L., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2010.11.020 · Cited by 127
Uritani, M., Hidaka, H., Hotta, Y., Ueno, M., Ushimaru, T., & Toda, T. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.01025.x · Cited by 124
Lysosomal adaptation: how the lysosome responds to external cues
Settembre, C., & Ballabio, A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016907 · Cited by 126
Cell Cycle Regulation by the Nutrient-Sensing Mammalian Target of Rapamycin (mTOR) Pathway
Cuyàs, E., Corominas-Faja, B., Joven, J., & Menéndez, J. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_7 · Cited by 128
Signaling from Akt to FRAP/TOR Targets both 4E-BP and S6K in Drosophila melanogaster
Miron, M., Lasko, P. F., & Sonenberg, N. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9117-9126.2003 · Cited by 127
Yasuda, M., Tanaka, Y., Kume, S., Morita, Y., Chin-Kanasaki, M., Araki, H., Isshiki, K., Araki, S.-I., Koya, D., Haneda, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.001 · Cited by 123
“Contents lists available at ScienceDirect Biochimica et Biophysica Acta j ourna l homepage: www.e lsev ie r .com/ locate /bbad is Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes Mako Yasuda a, Yuki Tanaka a, Shinji Kume a,⁎, Yoshikata Morita a, Masami Chin-Ka…”
InfluentialNoncanonical TGF-β pathways, mTORC1 and Abl, in renal interstitial fibrogenesis
Wang, S., Wilkes, M. C., Leof, E. B., & Hirschberg, R. R. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00320.2009 · Cited by 123
Krawiec, B. J., Nystrom, G. J., Frost, R. A., Jefferson, L. S., & Lang, C. H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00622.2006 · Cited by 125
Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway
Sage, V. L., Cinti, A., Amorim, R., & Mouland, A. J. (2016) · Viruses · doi:10.3390/v8060152 · Cited by 122
Uko, N. E., Güner, O. F., Matesic, D. F., & Bowen, J. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200224101808 · Cited by 125
mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
Liu, H.-J., Du, H., Khabibullin, D., Zarei, M., Wei, K., Freeman, G. J., Kwiatkowski, D. J., & Henske, E. P. (2023) · Nature Communications · doi:10.1038/s41467-023-36881-7 · Cited by 125
Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication
O’Shea, C. C., Klupsch, K., Choi, S., Bagus, B., Soria, C. T., Shen, J., McCormick, F. P., & Stokoe, D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600597 · Cited by 131
TOR‐mediated regulation of metabolism in aging
Antikainen, H., Driscoll, M., Haspel, G., & Dobrowolski, R. (2017) · Aging Cell · doi:10.1111/acel.12689 · Cited by 122
“TSC2 (Inoki et al., 2003), and directly by phosphorylating Raptor (Gwinn et al.”
BackgroundInfluentialGABAergic Interneuron Development and Function Is Modulated by the Tsc1 Gene
Fu, C., Cawthon, B., Clinkscales, W. B., Bruce, A., Winzenburger, P. A., & Ess, K. C. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr300 · Cited by 123
A lysosome-centered view of nutrient homeostasis
Mony, V. K., Benjamin-Davalos, S., & O’Rourke, E. J. (2016) · Autophagy · doi:10.1080/15548627.2016.1147671 · Cited by 122
Lysosomes: Signaling Hubs for Metabolic Sensing and Longevity
Savini, M., Zhao, Q., & Wang, M. C. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.08.008 · Cited by 116
Alam, H., Weck, J., Maizels, E. T., Park, Y., Lee, E. J., Ashcroft, M. A., & Hunzicker-Dunn, M. E. (2008) · Endocrinology · doi:10.1210/en.2008-0850 · Cited by 121
mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells
Goncharova, E. A., Goncharov, D. A., Li, H., Pimtong, W., Lu, S. M., Khavin, I., & Krymskaya, V. P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01061-10 · Cited by 122
Garcia, J. A., & Danielpour, D. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2408 · Cited by 120
Song, Z., Moore, D. R., Hodson, N. W., Ward, C., Dent, J. R., O’Leary, M. F., Shaw, A. M., Hamilton, D. L., Sarkar, S., Gangloff, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05483-x · Cited by 120
Sundberg, M., Tochitsky, I., Buchholz, D. E., Winden, K. D., Kujala, V. J., Kapur, K., Cataltepe, D., Turner, D., Han, M., Woolf, C. J., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0018-4 · Cited by 120
Key factors in mTOR regulation
Bai, X., & Jiang, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0163-7 · Cited by 123
Costa, V., Aigner, S., Vukcevic, M., Sauter, E. J., Behr, K., Ebeling, M., Dunkley, T. P. J., Friedlein, A., Zoffmann, S., Meyer, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.090 · Cited by 112
Santini, E., & Klann, E. (2014) · Science Signaling · doi:10.1126/scisignal.2005832 · Cited by 118
Autophagy in Human Health and Disease: Novel Therapeutic Opportunities
Giampieri, F., Afrin, S., Forbes-Hernández, T. Y., Gasparrini, M., Cianciosi, D., Reboredo‐Rodríguez, P., Varela‐López, A., Quiles, J. L., & Battino, M. A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7234 · Cited by 117
Chen, M., Wu, X., Gu, J., Guo, Q.-T., Shen, W., & Lu, P. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9153-0 · Cited by 115
The role of autophagy in cardiovascular pathology
Gatica, D., Chiong, M., Lavandero, S., & Klionsky, D. J. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab158 · Cited by 123
Nardella, C., Chen, Z., Salmena, L., Carracedo, A., Alimonti, A., Egia, A., Carver, B., Gerald, W., Cordon-Cardo, C., & Pandolfi, P. P. (2008) · Genes & Development · doi:10.1101/gad.1699608 · Cited by 121
Temporal Control of Differentiation by the Insulin Receptor/Tor Pathway in Drosophila
Bateman, J. E., & McNeill, H. (2004) · Cell · doi:10.1016/j.cell.2004.08.028 · Cited by 119
Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington’s disease
Pryor, W. M., Biagioli, M., Shahani, N., Swarnkar, S., Huang, W., Page, D. T., MacDonald, M. E., & Subramaniam, S. (2014) · Science Signaling · doi:10.1126/scisignal.2005633 · Cited by 111
Therapeutic targeting of the mTOR ‐signalling pathway in cancer: benefits and limitations
Moschetta, M., Reale, A., Marasco, C., Vacca, A., & Carratù, M. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12749 · Cited by 119
Phosphatidylinositol 3-Kinase: The Oncoprotein
Vogt, P. K., Hart, J. R., Gymnopoulos, M., Jiang, H., Kang, S., Bader, A. G., Zhao, L., & Denley, A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_80 · Cited by 117
Kang, Y. J., Lü, M., & Guan, K.-L. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.82 · Cited by 118
Self-citationEukaryotic translation initiation factors as promising targets in cancer therapy
Hao, P., Yu, J., Ward, R. J., Liu, Y., Qiao, H., An, S., & Xu, T. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00607-9 · Cited by 127
Self-citationMacropinocytosis, mTORC1 and cellular growth control
Yoshida, S., Pacitto, R., Inoki, K., & Swanson, J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2710-y · Cited by 114
Self-citationInterleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.
Johnson, C. N., Han, Y., Hughart, N., McCarra, J., Alpini, G. D., & Meng, F. (2012) · PubMed · doi:10.3978/j.issn.2224-4778.2011.11.02 · Cited by 114
Klement, R. J., & Fink, M. K. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.2 · Cited by 117
TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase
Goncharova, E. A., Goncharov, D. A., Noonan, D. J., & Krymskaya, V. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200405130 · Cited by 114
Lu, Z., Hu, X., Li, Y., Zheng, L., Zhou, Y., Jiang, H., Ning, T., Basang, Z., Zhang, C., & Ke, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403385200 · Cited by 114
Self-citationEssential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.
Ghosh, S., Tergaonkar, V., Rothlin, C., Correa, R., Bottero, V., Bist, P., Verma, I., & Hunter, T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.007 · Cited by 126
The Lysosome at the Intersection of Cellular Growth and Destruction
Shin, H. R., & Zoncu, R. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.010 · Cited by 121
Seeliger, H., Guba, M. O., Kleespies, A., Jauch, K., & Bruns, C. J. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9077-8 · Cited by 113
Tumorigenic activity and therapeutic inhibition of Rheb GTPasePreprint
Mavrakis, K. J., Zhu, H., Silva, R. L. A., Mills, J. R., Teruya‐Feldstein, J., Lowe, S. W., Tam, W., Pelletier, J., & Wendel, H. (2008) · Genes & Development · doi:10.1101/gad.1690808 · Cited by 113
Rydzanicz, M., Wrzesiński, T., Bluyssen, H. A. R., & Wesoły, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.006 · Cited by 112
STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
Orlova, K. A., Parker, W. E., Heuer, G. G., Tsai, V., Yoon, J. T., Baybis, M., Fenning, R. S., Strauss, K. A., & Crino, P. B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41592 · Cited by 114
Vázquez‐Manrique, R. P., Farina, F., Cambon, K., Sequedo, M. D., Parker, J. A., Millán, J. M., Weiss, A., Déglon, N., & Néri, C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv513 · Cited by 119
Metadata
- Authors
- Inoki, K., Li, Y., Xu, T., & Guan, K.-L.
- Affiliations
- University of Michigan (US)
- Howard Hughes Medical Institute (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2003-07-17
- Volume
- 17
- Issue
- 15
- Pages
- 1829-1834
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC196227
- OpenAlex
- W2056137479
- Cited by
- 1,911
- References
- 34
- Citations by year
- 2026: 44 · 2025: 68 · 2024: 75 · 2023: 78 · 2022: 72 · 2021: 107 · 2020: 103 · 2019: 73 · 2018: 97 · 2017: 112 · 2016: 111 · 2015: 127 · 2014: 92 · 2013: 101 · 2012: 94
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124709)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- TSC2, GTPase-activating protein, mTOR signaling, tuberous sclerosis complex, S6K phosphorylation, 4E-BP1 phosphorylation, rapamycin, nutrient signaling, cellular energy status, cell growth regulation, Ras family GTPases
- MeSH terms
- Ras Homolog Enriched in Brain Protein, Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Antibiotics, Antineoplastic, Cell Division, Cell Line, Dose-Response Relationship, Drug, Genes, Dominant, Guanosine Triphosphate, Humans, Hydrolysis, Models, Biological, Mutation, Neuropeptides, Phosphorylation, Plasmids, Protein Binding, Protein Kinases, Proteins, Repressor Proteins, Time Factors, Protein Biosynthesis, Signal Transduction, Protein Structure, Tertiary, Sirolimus, GTP Phosphohydrolases, Monomeric GTP-Binding Proteins, Tumor Suppressor Proteins, Ribosomal Protein S6 Kinases, 70-kDa, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review